IDXX vs TCRT · P/E 40, rev $2.36B vs $5.6M cap
IDEXX Laboratories Inc (IDXX) versus Alaunos Therapeutics Inc (TCRT) — a side-by-side from cached financials, not a winner call.
IDEXX Laboratories Inc (IDXX) is a diagnostics & research company listed on NASDAQ.
Alaunos Therapeutics Inc (TCRT) is a biotechnology company listed on NASDAQ.
Latest reported IDXX revenue for 2026-06-30 was $2.36B. Net income was $616.9M. IDXX currently screens at market cap $43.08B and trailing P/E 40.2.
Latest reported TCRT revenue for 2026-06-30 was $0. Net income was -$2.0M. TCRT currently screens at market cap $5.6M.
IDXX currently screens at market cap $43.08B and trailing P/E 40.2. TCRT currently screens at market cap $5.6M.
Not investment advice. Open the IDXX and TCRT stock pages for the full models.
Not investment advice.